RHOA and mature T-cell and NK-cell non-Hodgkin lymphoma: Large cell PTCL-TFH patients showed frequent expression of activation molecules and sometimes RHOA G17V mutation, and pursued a progressive clinical course in groups of TFH+ PTCLs.